Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Insulet

Insulet Stock: Analyst Estimates & Ratings

Insulet has significantly outpaced the broader market over the past year, and analysts remain very bullish on the stock’s prospects.

Barchart

Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.

The Omnipod maker reported 113% earnings growth, sending shares higher.

Investors Business Daily

Dow Jones Futures: Palantir, Oracle, Other Growth Leaders Keep Falling; What To Do Now

Palantir, Oracle, AMD and other growth leaders broke key levels Tuesday. Investors should take action.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Insulet Stock Breaks Out — Again — As Momentum Continues

Insulet is Tuesday's IBD Stock Of The Day after shares broke out following a "broad-based beat" for the June quarter.

Investors Business Daily

Insulet Earns Membership In 95-Plus Composite Rating Club

The IBD SmartSelect Composite Rating for Insulet increased from 89 to 96 Friday.

Investors Business Daily

Stocks Showing Improving Market Leadership: Insulet Earns 87 RS Rating

Insulet sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Insulet Corporation (NASDAQ:PODD) reported second-quarter adjusted earnings of $1.17 per share, beating the consensus of 92 cents.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises'

Insulet stock surged Thursday after the insulin pump-maker walloped second-quarter forecasts and raised its sales guidance for the year.

Investors Business Daily

Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids

Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.

Investors Business Daily

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

3 Medical Technology Stocks Outperforming in 2025

Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.

MarketBeat

Do Wall Street Analysts Like Insulet Stock?

Insulet has significantly outpaced the broader market over the past year, and analysts remain bullish on the stock’s prospects.

Barchart

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.

MarketBeat

Insulet Shows Market Leadership With Jump To 95 RS Rating

A Relative Strength Rating upgrade for Insulet shows improving technical performance.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Insulet Joins Rank Of Stocks With 95-Plus Composite Rating

Insulet saw its IBD SmartSelect Composite Rating rise to 98 Monday, up from 93 the day before.

Investors Business Daily

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

Visa has topped a buy point, while fellow S&P 500 component Insulet gapped out of a base, leading five stocks on this weekend watchlist.

Investors Business Daily

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

Stocks jumped Thursday on a Trump trade deal with the U.K., but pared gains on a report that Trump wants to hike taxes on the wealthy. Robinhood led new buys.

Investors Business Daily

Insulet Breaks Out In Bullish Fashion With 'Achievable And Conservative' Guidance On Deck

Insulet stock broke out Friday after the insulin pump-maker beat first-quarter forecasts and raised its outlook.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Here's What to Expect From Insulet's Next Earnings Report

Insulet is set to release its first-quarter results next month, and analysts expect a double-digit earnings growth.

Investors Business Daily

Stocks To Watch: Insulet Sees RS Rating Rise To 91

A Relative Strength Rating upgrade for Insulet shows improving technical performance.

Investors Business Daily

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Meta Stock Tests Support

Among the best stocks in earnings performance, Broadcom boasts a 98 EPS Rating, one of the highest in the chip sector.

Investors Business Daily

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

This medical device stock is in a base and its relative strength line hit a 52-week high. Insulet's insulin pump is now available in Canada.

Barchart

Insulet Stock: Is PODD Outperforming the Healthcare Sector?

As Insulet has outperformed relative to the healthcare sector over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Insulet Stock Outlook: Is Wall Street Bullish or Bearish?

Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

Earnings Preview: What to Expect From Insulet's Report

Insulet is scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit decline.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.